Changes in haematological variables with one-year treatment with pioglitazone, metformin and gliclazide in 3713 type 2 diabetic patients

被引：0
|
作者：
Belcher, G
Edwards, G
Urquhart, R
Eckland, D
Tan, M
Herz, M
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [41] Total and Acylated Ghrelin Levels in Type 2 Diabetic Patients: Similar Levels Observed after Treatment with Metformin, Pioglitazone or Diet Therapy
    Kiyici, S.
    Ersoy, C.
    Gul, O. Oz
    Sarandol, E.
    Demirci, M.
    Tuncel, E.
    Sigirli, D.
    Erturk, E.
    Imamoglu, S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2009, 117 (08) : 386 - 390
  • [42] Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients
    Li, Yue
    Ryu, Christina
    Munie, Metasebia
    Noorulla, Salma
    Rana, Satyesh
    Edwards, Paul
    Gao, Hua
    Qiao, Xiaoxi
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [43] Metabolic Surgery as a Treatment for Non-Obese Type 2 Diabetic Patients: Incretins, Adipocytokines and Insulin Secretion/Resistance Changes in a One-Year Interventional Clinical Controlled Study
    Geloneze, Bruno
    Geloneze, Sylka R.
    Chaim, Elinton
    Stabe, Christiane
    Hirsch, Fernanda F.
    Felici, Ana C.
    Lambert, Giselle
    Tambascia, Marcos A.
    Pareja, Jose C.
    DIABETES, 2011, 60 : A48 - A48
  • [44] Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study
    Mo, Dan
    Liu, Songfang
    Ma, Hong
    Tian, Haoming
    Yu, Honglin
    Zhang, Xiangxun
    Tong, Nanwei
    Liao, Jiayu
    Ren, Yan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2769 - 2776
  • [45] Obesity Connected Metabolic Changes in Type 2 Diabetic Patients Treated With Metformin
    Aleidi, Shereen M.
    Dahabiyeh, Lina A.
    Gu, Xinyun
    Al Dubayee, Mohammed
    Alshahrani, Awad
    Benabdelkamel, Hicham
    Mujammami, Muhammad
    Li, Liang
    Aljada, Ahmad
    Rahman, Anas M. Abdel
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [46] Evaluation of changes of glycaemic control and lipid parameters in patients with T2DM after one year of treatment with pioglitazone in combination with metformin or sulfonylurea in a Greek observational study
    Ginis, A. A.
    Karainanos, B.
    Charalampidou, E.
    Saridaki, A.
    Drossinos, V.
    DIABETOLOGIA, 2006, 49 : 490 - 491
  • [47] Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): Effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients
    Genovese, S.
    Passaro, A.
    Brunetti, P.
    Comaschi, M.
    Cucinotta, D.
    Egan, C. G.
    Chinea, B.
    Bravi, F.
    Di Pietro, C.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (08) : 606 - 616
  • [48] Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): Effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients
    S. Genovese
    A. Passaro
    P. Brunetti
    M. Comaschi
    D. Cucinotta
    C. G. Egan
    B. Chinea
    F. Bravi
    C. Di Pietro
    Journal of Endocrinological Investigation, 2013, 36 : 606 - 616
  • [49] Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone
    Ristic, S.
    Collober-Maugeais, C.
    Pecher, E.
    Cressier, F.
    DIABETIC MEDICINE, 2006, 23 (07) : 757 - 762
  • [50] One-Year Efficacy and Safety of the Telehealth System in Poorly Controlled Type 2 Diabetic Patients Receiving Insulin Therapy
    Chen, Shi-Yu
    Chang, Yu-Hung
    Hsu, Hui-Chun
    Lee, Yau-Jiunn
    Hung, Yi-Jen
    Hsieh, Chang-Hsun
    TELEMEDICINE AND E-HEALTH, 2011, 17 (09) : 683 - 687
12345